Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Department of Dermatology, University of Kiel, Kiel, Germany.
Annals of Oncology (Impact Factor: 6.58). 05/2009; 20 Suppl 4:129-31. DOI: 10.1093/annonc/mdp152
Source: PubMed
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose We analyzed patterns and factors associated with receipt of breast and cervical cancer screening in a cohort of colorectal cancer survivors. Methods Individuals diagnosed with colorectal cancer in Nova Scotia between January 2001 and December 2005 were eligible for inclusion. Receipt of breast and cervical cancer screening was determined using administrative data. General-population age restrictions were used in the analysis (breast: 40-69 years; cervical: 21-75 years). Kaplan-Meier and Cox proportional hazards models were used to assess time to first screen. Results Of 318 and 443 colorectal cancer survivors eligible for the breast and cervical cancer screening analysis respectively, 30.1% [95% confidence interval (CI): 21.2% to 39.0%] never received screening mammography, and 47.9% (95% CI: 37.8% to 58.0%) never received cervical cancer screening during the study period. Receipt of screening before the colorectal cancer diagnosis was strongly associated with receipt of screening after diagnosis (hazard ratio for breast cancer screening: 4.71; 95% CI: 3.42 to 6.51; hazard ratio for cervical cancer screening: 6.83; 95% CI: 4.58 to 10.16). Conclusions Many colorectal cancer survivors within general-population screening age recommendations did not receive breast and cervical cancer screening. Future research should focus on survivors who meet age recommendations for population-based cancer screening.
    Current Oncology 10/2014; 21(5):e670-7. DOI:10.3747/co.21.2090 · 1.64 Impact Factor
  • Surgical Oncology Clinics of North America 01/2015; DOI:10.1016/j.soc.2014.12.012 · 1.67 Impact Factor

Full-text (2 Sources)

Available from
Aug 26, 2014